Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MAPKAPK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IL10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYRK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF2D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL20 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASSF5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL24 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FCMR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IKBKE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIGR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRGAP2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on